The future of rheumatoid arthritis treatment.
Publication
, Journal Article
St Clair, EW; Haynes, BF
Published in: Bull Rheum Dis
April 1993
Research into the molecular mechanisms of immunological diseases and the development of more specific therapies are moving ahead simultaneously at a rapid pace. This information may provide a better paradigm for understanding the pathogenesis and the prospects for interventional immunotherapy of RA.
Duke Scholars
Published In
Bull Rheum Dis
ISSN
0007-5248
Publication Date
April 1993
Volume
42
Issue
2
Start / End Page
1 / 4
Location
United States
Related Subject Headings
- T-Lymphocytes
- Lymphocyte Activation
- Immunotherapy
- Humans
- Forecasting
- Cytokines
- Cell Adhesion Molecules
- Arthritis, Rheumatoid
- Arthritis & Rheumatology
Citation
APA
Chicago
ICMJE
MLA
NLM
St Clair, E. W., & Haynes, B. F. (1993). The future of rheumatoid arthritis treatment. Bull Rheum Dis, 42(2), 1–4.
St Clair, E. W., and B. F. Haynes. “The future of rheumatoid arthritis treatment.” Bull Rheum Dis 42, no. 2 (April 1993): 1–4.
St Clair EW, Haynes BF. The future of rheumatoid arthritis treatment. Bull Rheum Dis. 1993 Apr;42(2):1–4.
St Clair, E. W., and B. F. Haynes. “The future of rheumatoid arthritis treatment.” Bull Rheum Dis, vol. 42, no. 2, Apr. 1993, pp. 1–4.
St Clair EW, Haynes BF. The future of rheumatoid arthritis treatment. Bull Rheum Dis. 1993 Apr;42(2):1–4.
Published In
Bull Rheum Dis
ISSN
0007-5248
Publication Date
April 1993
Volume
42
Issue
2
Start / End Page
1 / 4
Location
United States
Related Subject Headings
- T-Lymphocytes
- Lymphocyte Activation
- Immunotherapy
- Humans
- Forecasting
- Cytokines
- Cell Adhesion Molecules
- Arthritis, Rheumatoid
- Arthritis & Rheumatology